Research

A collection of the latest research and findings in the respiratory space

Research

Filter by topic:

All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis:

Jonathan R Baker, PhD Mahdi Mahdi, BSc Dan V Nicolau Jr, PhD Sanjay Ramakrishnan, MBBS Prof Peter J Barnes, FRS Jodie L Simpson, PhD et al.

7 April, 2022

NZ Respiratory Research Review Issue 200

The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature:

Lesley J.J. Soril a,b , Ronald W. Damant a,c , Grace Y. Lam c , Maeve P. Smith c , Jason Weatherald d , Jean Bourbeau e , Paul Hernandez f , Michael K. Stickland

1 March, 2022

NZ Respiratory Research Review Issue 196

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study:

Ruvim Izikson, MD Daniel Brune, MD Jean-Sébastien Bolduc, PhD Pierre Bourron, PharmD Marion Fournier, MSc Tamala Mallett Moore, MD et al.

31 January, 2022

NZ Respiratory Research Review Issue 196

Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey :

Keir Elmslie James Philip, Sara Buttery, Parris Williams, Bavithra Vijayakumar, James Tonkin, Andrew Cumella, Lottie Renwick, Lizzie Ogden, Jennifer K Quint, Sebastian L Johnston, Michael I Polkey, Nicholas S Hopkinson

13 January, 2022

NZ Respiratory Research Review Issue 200

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial:

Seth Toback, MD Eva Galiza, MBBS Catherine Cosgrove, PhD James Galloway, PhD Anna L Goodman, DPhil Pauline A Swift, PhD et al.

17 November, 2021

NZ Respiratory Research Review Issue 196

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study:

Rachael A Evans, PhD,Hamish McAuley, MBBS, Prof Ewen M Harrison, PhD, Aarti Shikotra, PhD Amisha Singapuri, BSc Marco Sereno, MSc et al.

7 October, 2021

NZ Respiratory Research Review Issue 196

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort:

Ashley K Clift, Adam von Ende, Pui San Tan, Hannah M Sallis, Nicola Lindson, Carol A C Coupland, Marcus R Munafò, Paul Aveyard , Julia Hippisley-Cox, Jemma C Hopewell

27 September, 2021

NZ Respiratory Research Review Issue 196

Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data :

Pontus Hedberg, John Karlsson Valik, Suzanne van der Werff, Hideyuki Tanushi, Ana Requena Mendez, Fredrik Granath, Max Bell, Johan Mårtensson, Robert Dyrdak, Olof Hertting, Anna Färnert, Anders Ternhag, Pontus Naucler

5 July, 2021

NZ Respiratory Research Review Issue 196

Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data:

Syed A Shah, Jennifer K Quint, Bright I Nwaru, Aziz Sheikh

29 March, 2021

NZ Respiratory Research Review Issue 194

Effect of Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters - A Randomized Clinical Trial:

Ian M. Kratzke, MD; Marcy E. Rosenbaum, PhD; Chase Cox, MD; David W. Ollila, MD; Muneera R. Kapadia, MD, MME

11 March, 2021

NZ Respiratory Research Review Issue 184